February 16, 2017 — Cerveau Technologies Inc. announced it has signed an agreement with Siemens’ PETNET Solutions...
Nuclear Imaging
Molecular imaging, also called nuclear imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI.
News | Radiopharmaceuticals and Tracers | February 16, 2017
News | Radiopharmaceuticals and Tracers | February 07, 2017
February 7, 2017 — Blue Earth Diagnostics and Siemens’ PETNET Solutions announced that an increasing number of...
Comparative receptor autoradiography in various cancer types (A = HE staining) with I-125-JR11 (B+C) and I-125-Tyr3-octreotide (D+E). B and D are the respective total binding, C and E the respective non-specific binding. Bars = 1 mm.
I: Breast cancer. II: Renal cell cancer. III: Medullary thyroid cancer. IV: Non-Hodgkin lymphoma. V: Colon cancer. In cancers I-V, the sections were incubated with 30’000 cpm/100 μl of antagonist or agonist. Cancers I-IV show a much higher density of sst2 with the antagonist. The colon cancer V is negative. VI: Ileal NET, incubated with 10’000 cpm/100 μl of antagonist or agonist. Credit: Jean Claude Reubi, Institute of Pathology, University of Berne, Berne, Switzerland.
News | Radiation Therapy | February 06, 2017
February 6, 2017 — A study published in the February issue of...
Sponsored Content
Staging F18FDG PET/CT images of adenocarcinoma in the RUL (right upper lobe) of the lung illustrates the value of Vereos. The primary lesion in the right upper lobe appears in the upper row (PET image is left, CT image is right). A 3 mm synchronous primary or metastatic lesion in the RUL is apparent in the lower row. The precision afforded by Vereos' images provided the basis for the patient to undergo RUL lobectomy instead of thermal ablation of the primary lesion. (Images courtesy of Dr. Jay Kikut and UVMC)
Blog | PET-CT | October 25, 2018
Efficiency and effectiveness are inseparable in clinical medicine. Digital PET addresses them both.
Ga-68-BBN PET/CT of a 64-year-old man newly diagnosed with prostate cancer by biopsy. Multiple bone metastasis lesions (arrows) were detected. Image courtesy of Jingjing Zhang, Peking Union Medical College, Beijing, China.
News | Prostate Cancer | February 02, 2017
February 2, 2017 — In the featured article from the February 2017 issue of the Journal of Nuclear Medicine,...
News | Nuclear Imaging | January 30, 2017
January 30, 2017 — IBA Molecular has successfully completed its acquisition of Mallinckrodt Nuclear Imaging,...
News | Breast Imaging | January 26, 2017
January 26, 2017 — Gamma Medica recently announced that through its collaboration with Ohio-based Alpha Imaging,...
News | PET Imaging | January 25, 2017
January 25, 2017 — In work published this week in the Journal of Clinical Investigation (JCI), a team led by Jacob...
News | Radiopharmaceuticals and Tracers | January 17, 2017
January 17, 2017 — NorthStar Medical Technologies LLC has received additional matching funds from the U.S....
News | Nuclear Imaging | January 12, 2017
January 12, 2017 — Bayer Healthcare has initiated a recall of all its Medrad Intego PET Infusion System Source...
SPECT/CT reconstructions and VOIs used for determination of calibration factors for the adult kidney filled with Lu-177 (A) and the corresponding sphere filled with I-131 (B). Credit: University of Würzburg
News | Medical 3-D Printing | January 06, 2017
January 6, 2017 — In nuclear medicine, the goal is to keep radiation exposure at a minimum, while obtaining quality...
News | Radiopharmaceuticals and Tracers | January 06, 2017
January 6, 2017 — New research demonstrates that a novel...
News | Nuclear Imaging | January 05, 2017
January 5, 2017 — Working in concert, the American Society of Nuclear Cardiology (ASNC), the Intersocietal...
News | Radiation Therapy | January 03, 2017
January 3, 2017 — Sirtex Medical Limited announced in December that SIR-Spheres Y-90 resin microspheres have been...
News | December 28, 2016
December 28, 2016 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has developed United States...
News | Prostate Cancer | December 22, 2016
Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics...
News | Prostate Cancer | December 14, 2016
December 14, 2016 — Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on...
News | Nuclear Imaging | December 12, 2016
Molecular Targeting Technologies, Inc. (MTTI) announces that response of colorectal cancer to treatment can be...
News | Radiation Dose Management | December 08, 2016
December 8, 2016 — Numa introduced a new software application at the 2016 Annual Meeting of the Radiological Society...
